TY  - JOUR

T1  - Efficacy and safety of abrocitinib in patients with severe and/or difficult-to-treat atopic dermatitis: a post hoc analysis of the randomized phase 3 JADE COMPARE trial

JO  - American Journal of Clinical Dermatology

UR  - https://eprints.whiterose.ac.uk/id/eprint/201122

UR  - http://dx.doi.org/10.1007/s40257-023-00785-5

PY  - 2023/05/22

AU  - Simpson EL

AU  - Silverberg JI

AU  - Thyssen JP

AU  - Viguier M

AU  - Thaçi D

AU  - de Bruin-Weller M

AU  - Weidinger S

AU  - Chan G

AU  - DiBonaventura M

AU  - Biswas P

AU  - Feeney C et al

ED  - 

DO  - DOI: 10.1007/s40257-023-00785-5

PB  - Springer Science and Business Media LLC

VL  - 24

SP  - 609

EP  - 621

Y2  - 2024/12/22

ER  -